Mary Beth Kossuth Ph.D. joined Abbott in 2009 as a Staff Research Scientist in the Research and Development (R&D) group in Santa Clara, California. She is currently a Senior Associate Research Fellow in the Abbott Vascular Global Product Development organization.
Previously, she was a Senior Staff Scientist for Symyx Technologies, managing collaborative research programs in combinatorial materials science, with industrial partners in personal care, commodity chemicals, and specialty polymers.
While at Abbott, Dr. Kossuth has spent significant time focusing on resorbable devices, serving as the technical lead for the second-generation resorbable vascular scaffold, also called the Esprit BTK System, approved by the U.S. Food and Drug Administration (FDA) in 2024 for use in the U.S. as a first-of-its-kind device for the treatment of Peripheral Artery Disease and Critical Limb-Threatening Ischemia (CLTI) below the knee (BTK). Her additional responsibilities include managing a team of subject matter experts across the materials science and engineering disciplines.
Dr. Kossuth received a bachelor’s degree from the Massachusetts Institute of Technology (MIT) and earned her Ph.D. from the University of Minnesota, Twin Cities. Both degrees are in Materials Science and Engineering. She has authored or co-authored more than 10 publications and been granted or applied for more than 23 patents.